United States Cardiovascular Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The United States cardiovascular devices market is segmented by device type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices).

Market Snapshot

Market Snapshot1
Study Period:

2018 - 2026

Base Year:

2019

CAGR:

4.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The United States Cardiovascular Devices Market is expected to register a CAGR of 4.8% during the forecast period. The major factors driving the growth of the market in the United States are due to the presence of established healthcare infrastructure, rapid technological advancements, increasing burden of cardiovascular diseases, and increased adoption of minimally invasive procedures.

As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030.

Furthermore, due to ongoing development in the cardiovascular field and technological advancements are also expected to propel the growth of the United States cardiovascular devices market.

Scope of the report

As per the scope of the report, Cardiovascular diseases are a group of disorders of the heart and blood vessels that includes coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. The cardiovascular devices are used to treat or prevent different cardiovascular conditions. The United States Cardiovascular Devices Market is segmented by device type.

By Device Type
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period

An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.

Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Moreover, there has been an increase in the incidence of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.

According to the Heart Disease and Stroke Statistics 2019 report, estimates that in 2019, coronary events were expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events in the United States.

Furthermore, increasing cardiovascular diseases, such as high blood pressure, arrhythmias, and stroke are increasing the demand for cardiovascular devices, along with growing demand for minimally invasive surgeries and technological advancements are also expected to drive the market in near future.

USA Cardio key trend 1.png

To understand key trends, Download Sample Report

Competitive Landscape

The United States cardiovascular devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Medtronic PLC, Cardinal Health Inc., GE Healthcare, Biotronik, Siemens Healthineers AG and W. L. Gore & Associates, Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rapid Technological Advancements

      2. 4.2.2 Increasing Burden of Cardiovascular Diseases

      3. 4.2.3 Increased Preference of Minimally Invasive Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Policies

      2. 4.3.2 High Cost of Instruments and Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device Type

      1. 5.1.1 Diagnostic and Monitoring Devices

        1. 5.1.1.1 Electrocardiogram (ECG)

        2. 5.1.1.2 Remote Cardiac Monitoring

        3. 5.1.1.3 Other Diagnostic and Monitoring Devices

      2. 5.1.2 Therapeutic and Surgical Devices

        1. 5.1.2.1 Cardiac Assist Devices

        2. 5.1.2.2 Cardiac Rhythm Management Device

        3. 5.1.2.3 Catheter

        4. 5.1.2.4 Grafts

        5. 5.1.2.5 Heart Valves

        6. 5.1.2.6 Stents

        7. 5.1.2.7 Other Therapeutic and Surgical Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Edwards Lifesciences

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 Cardinal Health Inc.

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Biotronik

      8. 6.1.8 Siemens Healthineers AG

      9. 6.1.9 W. L. Gore & Associates, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The United States Cardiovascular Devices Market market is studied from 2018 - 2026.

The United States Cardiovascular Devices Market is growing at a CAGR of 4.8% over the next 5 years.

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Medtronic PLC
  • Cardinal Health Inc.

Are the major companies operating in United States Cardiovascular Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!